Lebanon Indiana - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Eli Lilly’s retatrutide moves closer to a planned 2027 U.S. filing after completing its core Phase 3 programme for obesity, knee pain and sleep apnea. Representative image.

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

India and Canada are accelerating CEPA negotiations as LNG, nuclear energy and critical minerals become central to their expanding economic relationship. Representative image.

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

The White House press-access dispute intensified after MS NOW journalists said their credentials were disabled following Donald Trump’s media ban. Representative image.

Trump White House media ban takes effect as MS NOW journalists are turned away

Smoke near Riyadh’s King Khalid International Airport followed Saudi aerial danger alerts as the conflict with Yemen’s Houthis intensifies. Representative image.

Smoke rises near Riyadh airport after Saudi aerial alerts as Houthi conflict escalates

Representative image of a sterile pharmaceutical manufacturing line, reflecting Eli Lilly and Company’s $4.5 billion Indiana expansion to scale obesity drug, GLP-1 and genetic medicine production capacity.

Read More

Pharma Industry News

Is Eli Lilly (LLY) building the obesity drug supply chain nobody else can easily match?

Lilly’s obesity pipeline needs industrial muscle. Its $4.5bn Indiana bet shows why manufacturing may decide the next GLP-1 race.

May 28, 2026

Read More

Pharma Industry News

Lilly’s $4.5bn Medicine Foundry aims to redefine how clinical trial drugs are made

Find out how Eli Lilly and Company’s $4.5bn Medicine Foundry aims to transform clinical trial manufacturing and accelerate next-generation therapies.

October 3, 2024

web analytics